Announcements and Notices - [Final Results / Modified Report by Auditors / Closure of Books or Change of Book Closure Period]

Immunotech Biopharm Ltd operates as a biopharmaceutical company. The Company develops and produces cellular immunotherapy products and other products. Immunotech Biopharm markets its products throughout China.

Announcement Of Annual Results
For The Year Ended 31 December 2024

Announcements and Notices - [Other - Business Update]

Voluntary Announcement
Conditional New Drug Application Of Eal Accepted By
The National Medical Products Administration

Announcements and Notices - [Date of Board Meeting]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Immunotech Biopharm (6978 HK)

Announcement Of Annual Results For The Year Ended 31 December 2024

Voluntary Announcement Conditional New Drug Application Of Eal Accepted By The National Medical Products Administration

Postponement Of Board Meeting

Date Of Board Meeting

Voluntary Announcement Business Update - Recent Development Of Eal

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)